33
Table 2.1: Toxicity frequency for randomized eligible patients by study arms. In the
placebo (Isotretinoin) group, 171 (427) out of 577 (589) patients exhibited some type
of toxicity. In bold the proportion of patients in the study arm belonging to the cell.
Placebo
|
Toxic effect |
No Tox |
Gl |
G2 |
G3 |
G4 |
|
Abnormal vision |
565(0.979) |
9(0.016) |
0(0) |
2(0.003) |
1(0.002) |
|
Arthralgia |
548(0.95) |
19(0.033) |
10(0.017) |
0(0) |
- |
|
Cheilitis |
493(0.854) |
76(0.132) |
8(0.014) |
0(0) |
- |
|
Conjunctivitis |
530(0.919) |
43(0.075) |
3(0.005) |
1(0.002) |
- |
|
Fatigue |
558(0.967) |
12(0.021) |
5(0.009) |
2(0.003) |
- |
|
Headache |
554(0.96) |
16(0.028) |
3(0.005) |
4(0.007) |
- |
|
Hyper-triglyceride |
551(0.955) |
22(0.038) |
4(0.007) |
0(0) |
- |
|
Isotretinoin | |||||
|
Abnormal vision |
579(0.983) |
8(0.014) |
1(0.002) |
1(0.002) |
0(0) |
|
Arthralgia |
544(0.924) |
30(0.051) |
10(0.017) |
5(0.008) |
- |
|
Cheilitis |
212(0.36) |
245(0.416) |
122(0.207) |
10(0.017) |
- |
|
Conjunctivitis |
449(0.762) |
98(0.166) |
31(0.053) |
11(0.019) |
- |
|
Fatigue |
572(0.971) |
14(0.024) |
3(0.005) |
0(0) |
- |
|
Headache |
580(0.985) |
9(0.015) |
0(0) |
0(0) |
- |
|
Hyper-triglyceride |
514(0.873) |
64(0.109) |
10(0.017) |
1(0.002) |
- |
More intriguing information
1. Delayed Manifestation of T ransurethral Syndrome as a Complication of T ransurethral Prostatic Resection2. Deletion of a mycobacterial gene encoding a reductase leads to an altered cell wall containing β-oxo-mycolic acid analogues, and the accumulation of long-chain ketones related to mycolic acids
3. Structural Influences on Participation Rates: A Canada-U.S. Comparison
4. Trade Openness and Volatility
5. Using Surveys Effectively: What are Impact Surveys?
6. Regional Intergration and Migration: An Economic Geography Model with Hetergenous Labour Force
7. The name is absent
8. EXECUTIVE SUMMARY
9. The name is absent
10. Handling the measurement error problem by means of panel data: Moment methods applied on firm data